Shanmukh Sai Pavan Lingamsetty
@lshanmukh05
Followers
74
Following
3K
Media
2
Statuses
23
IM Residency Applicant | Postdoc Fellow at Beth Israel Deaconess Medical Center | @harvardmed
India
Joined April 2015
RT @IuriFFelix: Please check out our latest 📝 on the outcomes of patients with Chagas’ disease undergoing CRT 🫀⚡️. ⬆️ LVEF.⬇️ NYHA Class.📌….
0
1
0
RT @MohamedDomaa: Check out my recent talk with the amazing Dr. @AGoldsweig on mechanical outcomes of #IVUS vs #OCT guided coronary stentin….
0
3
0
Generate videos in just a few seconds. Try Grok Imagine, free for a limited time.
1K
3K
11K
RT @MichaelMegalyMD: It might be subtle differences but sizing might be a bit better using IVUS. I wonder what OCT enthusiasts think.
0
2
0
RT @KrityaMangesh: Glad to be part of this amazing team. Huge congrats to @lshanmukh05 & @MohamedDomaa for their amazing work on this paper….
0
1
0
Huge thanks to @MohamedDomaa for the thread. Proud to lead this meta-analysis comparing IVUS vs. OCT in PCI across 6 RCTs. "IVUS yielded larger MSA & less residual stenosis.". Special thanks to our senior authors @AGoldsweig, @MichaelMegalyMD , @Babar_Basir , and @arnoldseto.
Which imaging modality optimizes PCI, IVUS or OCT?.We compared mechanical outcomes of coronary stenting using IVUS vs. OCT across 6 RCTs and 2,696 patients. Shoutout to my superstar friend @lshanmukh05 for leading this. @IJCardio .🔗Full paper: 1/4
1
2
8
RT @mandeep_mayo: Here are 10 reasons NOT to routinely pre-treat NSTE-ACS patients with P2Y12 inhibitors
0
56
0
Excited to share that our abstracts are being presented as oral and poster presentations #SCAI2025! 🫀.Meet our incredible team & presenters —Sahas Jitta, Kesar Prajapati, and @MohamedDomaa .📅 May 1–3, 2025.📍Washington, D.C. #SCAI2025 #SCAINews #SCAITV #Cardiology
0
0
5
🚨 Week of Wins: Proud to Share Another Publication in @ccijournal . Our latest meta-analysis: Complete revascularization vs. culprit-only PCI in NSTE-ACS & MVD, is now out! 🔍.@harshi_md . . #Cardiology #NSTEACS #NSTEMI #ACS #Guidelines #ACC #AHA.
onlinelibrary.wiley.com
Objective Contemporary data have demonstrated that a complete revascularization (CR) strategy reduces adverse cardiovascular events compared with culprit vessel only-Percutaneous Coronary Intervent...
0
2
5
Excited to share our manuscript:."Safety and Efficacy of Intravascular Lithotripsy in Calcified Left Main Coronary Artery Disease: A Systematic Review and Meta‐Analysis" @ccijournal. Grateful for the incredible mentorship from @harshi_md and @vikjag45 .
onlinelibrary.wiley.com
Background Intravascular lithotripsy (IVL) has emerged as a novel therapeutic modality for the management of calcified coronary lesions. The effectiveness and safety of IVL specifically in the...
2
1
6
RT @sahibs559: New publication @ccijournal. Thank you @lshanmukh05 @harshi_md @dipesh_ludhwani @vikjag45 and all other co-authors. https:….
0
1
0
RT @MohamedDomaa: Always a pleasure to connect and discuss science from the beautiful city of Chicago. Grateful to the opportunity. #ACC25….
0
5
0
RT @KrityaMangesh: Poster presentation @ACCinTouch today. Presented a study on the role of pre-procedural fasting prior to cardiac catheter….
0
6
0
🚨 ECFMG certified (Step 2: 253) | Proficient in R . Seeking #Cardiology research positions. 🔬 Skilled in Meta-analysis and curating Kaplan-Meier curves using R. 📑 30+ abstracts/publications. 🌍Presentations at ESC 24, AHA 24, and SCAI 25. #MedTwitter #InsideTheMatch.
1
10
21
I went unmatched this cycle, but I'm keeping the grind on! 💪.If any PGY-1 positions open up, please let me know!.#UNMATCHED #MATCHDAY #Match2025 #MedTwitter #InsideTheMatch
3
6
20
RT @KumarManoj_MD: Amazing talk by @Babar_Basir on understanding the results of Danger Shock trial and urgent need for standardized practic….
0
3
0
RT @walinjom: New ESC Guidelines on #Atrial #Fibrillation #esccongress2024. The updated #CHA2DS2 Va score:.What is new?. 👇.➡️ C: chronic HF….
0
43
0